Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
March 16, 2023Expert Review of Pharmacoeconomics & Outcomes ResearchOpen Access

Estimate of the cost per responder for treatment with biological therapies of moderate-to-severe plaque psoriasis in Colombia for first-year and maintenance periods

View Full Paper
Ask AI
Bookmark
Share

Authors

PLPieralessandro LasalviaYGYaneth Gil-RojasEPEmmanuel Papadimitropoulos

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lasalvia et al. (2023) studied this question.

synapsesocial.com/papers/6aa697806cd58dd9e9f4e6abhttps://doi.org/10.1080/14737167.2023.2190514
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1PASI 90 response: the new standard in therapeutic efficacy for psoriasis2014 · 194 citations
  2. 2Use of Secukinumab in a Cohort of Erythrodermic Psoriatic Patients: A Pilot Study2019 · 38 citations
  3. 3Cumulative Clinical Benefits of Biologics in the Treatment of Patients with Moderate-to-Severe Psoriasis over 1 Year: a Network Meta-Analysis2022 · 21 citations
  4. 4Long‐term efficacy of novel therapies in moderate‐to‐severe plaque psoriasis: a systematic review and network meta‐analysis of PASI response2018 · 101 citations